NGVT - Ingevity Corporation
NYSE
->
Basic Materials
->
Specialty Chemicals
North Charleston,
United States
Type: Equity
NGVT price evolution
NGVT
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $88.5 | $95.9 | $84.5 | $68 |
| Short term investments | ||||
| Net receivables | $191.3 | $182 | $216.6 | $259.7 |
| Inventory | $325.5 | $308.8 | $386.7 | $387.1 |
| Total current assets | $669.2 | $658.6 | $734.5 | $764.4 |
| Long term investments | $173.9 | $178.3 | $179.5 | $178.9 |
| Property, plant & equipment | $790.1 | $829.3 | $868.7 | $867.1 |
| Goodwill & intangible assets | $828.7 | $863.6 | $895.7 | $921.3 |
| Total noncurrent assets | $1897.7 | $1964.7 | $2032.3 | $2063.9 |
| Total investments | $173.9 | $178.3 | $179.5 | $178.9 |
| Total assets | $2566.9 | $2623.3 | $2766.8 | $2828.3 |
| Current liabilities | ||||
| Accounts payable | $153.1 | $158.4 | $197.3 | $203.6 |
| Deferred revenue | ||||
| Short long term debt | $103.5 | $103.1 | $21.4 | $18.6 |
| Total current liabilities | $351.7 | $362.9 | $305.1 | $311.1 |
| Long term debt | $1453.7 | $1431.4 | $1520.3 | $1574.7 |
| Total noncurrent liabilities | $1647 | $1629 | $1743 | $1803.1 |
| Total debt | $1557.2 | $1534.5 | $1541.7 | $1593.3 |
| Total liabilities | $1998.7 | $1991.9 | $2048.1 | $2114.2 |
| Shareholders' equity | ||||
| Retained earnings | $946.3 | $1002.3 | $1119.1 | $1093.9 |
| Other shareholder equity | -$35.6 | -$26.7 | -$53.9 | -$33.5 |
| Total shareholder equity | $568.2 | $631.4 | $718.7 | $714.1 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $95.9 | $76.7 | $275.4 | $257.7 |
| Short term investments | ||||
| Net receivables | $182 | $249.3 | $161.7 | $148 |
| Inventory | $308.8 | $335 | $241.2 | $189 |
| Total current assets | $658.6 | $679 | $724.9 | $628.7 |
| Long term investments | $178.3 | $187.8 | $76.1 | $73.6 |
| Property, plant & equipment | $829.3 | $855.3 | $772.1 | $752.7 |
| Goodwill & intangible assets | $863.6 | $923.3 | $779.6 | $818.6 |
| Total noncurrent assets | $1964.7 | $2057.5 | $1744.1 | $1705.8 |
| Total investments | $178.3 | $187.8 | $76.1 | $73.6 |
| Total assets | $2623.3 | $2736.5 | $2469 | $2334.5 |
| Current liabilities | ||||
| Accounts payable | $158.4 | $174.8 | $125.8 | $104.2 |
| Deferred revenue | ||||
| Short long term debt | $103.1 | $17.4 | $37 | $42.2 |
| Total current liabilities | $362.9 | $303.5 | $268.9 | $223.4 |
| Long term debt | $1431.4 | $1472.5 | $1286.2 | $1302.1 |
| Total noncurrent liabilities | $1629 | $1734.7 | $1526.3 | $1469 |
| Total debt | $1534.5 | $1530.7 | $1323.2 | $1344.3 |
| Total liabilities | $1991.9 | $2038.2 | $1795.2 | $1692.4 |
| Shareholders' equity | ||||
| Retained earnings | $1002.3 | $1007.7 | $796.1 | $678 |
| Other shareholder equity | -$26.7 | -$46.8 | $13.1 | $4.7 |
| Total shareholder equity | $631.4 | $698.3 | $673.8 | $642.1 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $340.1 | $371.7 | $446 | $481.8 |
| Cost of revenue | $240.4 | $312.2 | $317 | $328.8 |
| Gross Profit | $99.7 | $59.5 | $129 | $153 |
| Operating activities | ||||
| Research & development | $6.8 | $7.2 | $7.8 | $8 |
| Selling, general & administrative | $47.2 | $43.4 | $40 | $51.7 |
| Total operating expenses | $117.1 | $171.2 | $72.5 | $80.7 |
| Operating income | -$17.4 | -$111.7 | $56.5 | $72.3 |
| Income from continuing operations | ||||
| EBIT | -$49.6 | -$125 | $55.2 | $69.3 |
| Income tax expense | -$15.9 | -$37.2 | $6.9 | $12.2 |
| Interest expense | $22.3 | $29 | $23.1 | $21.6 |
| Net income | ||||
| Net income | -$56 | -$116.8 | $25.2 | $35.5 |
| Income (for common shares) | -$56 | -$116.8 | $25.2 | $35.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1692.1 | $1668.3 | $1391.5 | $1216.1 |
| Cost of revenue | $1220.2 | $1098.2 | $878.7 | $750.6 |
| Gross Profit | $471.9 | $570.1 | $512.8 | $465.5 |
| Operating activities | ||||
| Research & development | $31.8 | $30.3 | $26.3 | $22.6 |
| Selling, general & administrative | $183.7 | $198.8 | $179.3 | $149.4 |
| Total operating expenses | $389.3 | $247.9 | $222.4 | $192.3 |
| Operating income | $82.6 | $322.2 | $290.4 | $273.2 |
| Income from continuing operations | ||||
| EBIT | $83.2 | $331.4 | $214.5 | $282.2 |
| Income tax expense | -$4.7 | $58 | $44.7 | $53.7 |
| Interest expense | $93.3 | $61.8 | $51.7 | $47.1 |
| Net income | ||||
| Net income | -$5.4 | $211.6 | $118.1 | $181.4 |
| Income (for common shares) | -$5.4 | $211.6 | $118.1 | $181.4 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$56 | -$116.8 | $25.2 | $35.5 |
| Operating activities | ||||
| Depreciation | $34.5 | $29.9 | $40.1 | $36 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.3 | $2.3 | -$0.6 | $4.9 |
| Total cash flows from operations | -$12.1 | $44.6 | $106.9 | $48.4 |
| Investing activities | ||||
| Capital expenditures | -$16.6 | -$29.2 | -$33.5 | -$21.7 |
| Investments | -$2.3 | |||
| Total cash flows from investing | -$16.3 | -$21 | -$34.8 | -$23.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.7 | -$57.3 | ||
| Net borrowings | $26 | -$6.5 | -$53.7 | $22.8 |
| Total cash flows from financing | $23.4 | -$6.5 | -$53.3 | -$34.5 |
| Effect of exchange rate | -$1.8 | $2.7 | -$2.3 | -$0.3 |
| Change in cash and equivalents | -$5 | $17.1 | $18.8 | -$9.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$5.4 | $211.6 | $118.1 | $181.4 |
| Operating activities | ||||
| Depreciation | $141.4 | $124.9 | $127.2 | $118.2 |
| Business acquisitions & disposals | -$344.5 | |||
| Stock-based compensation | $10.6 | $16.1 | $12.3 | $8.4 |
| Total cash flows from operations | $205.1 | $313.1 | $293 | $352.4 |
| Investing activities | ||||
| Capital expenditures | -$109.8 | -$142.5 | -$103.8 | -$105.9 |
| Investments | $29.1 | -$62.7 | -$35.3 | -$2 |
| Total cash flows from investing | -$77.3 | -$553.9 | -$140.6 | -$110.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$87.4 | -$141.1 | -$104.7 | -$84.4 |
| Net borrowings | -$7.7 | $196 | -$26 | $37.4 |
| Total cash flows from financing | -$99.9 | $48.1 | -$133.1 | -$50.2 |
| Effect of exchange rate | -$0.3 | -$6 | -$1.7 | $2.2 |
| Change in cash and equivalents | $27.9 | -$192.7 | $19.3 | $191.6 |
News
Fundamentals
| Market cap | $1.97B |
|---|---|
| Enterprise value | $3.44B |
| Shares outstanding | 36.25M |
| Revenue | $1.64B |
|---|---|
| EBITDA | $90.40M |
| EBIT | -$50.10M |
| Net Income | -$112.10M |
| Revenue Q/Q | -13.37% |
| Revenue Y/Y | -2.29% |
| P/E ratio | -17.62 |
|---|---|
| EV/Sales | 2.10 |
| EV/EBITDA | 38.09 |
| EV/EBIT | -68.73 |
| P/S ratio | 1.20 |
| P/B ratio | 3.27 |
| Book/Share | 16.66 |
| Cash/Share | 2.44 |
| EPS | -$3.09 |
|---|---|
| ROA | -4.16% |
| ROE | -17.03% |
| Debt/Equity | 3.15 |
|---|---|
| Net debt/EBITDA | 21.13 |
| Current ratio | 1.90 |
| Quick ratio | 0.98 |